NM_145115.3:c.503G>C
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_145115.3(ZSCAN25):c.503G>C(p.Gly168Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000036 in 1,582,054 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_145115.3 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000328 AC: 5AN: 152250Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000252 AC: 6AN: 238442 AF XY: 0.0000232 show subpopulations
GnomAD4 exome AF: 0.0000364 AC: 52AN: 1429804Hom.: 0 Cov.: 30 AF XY: 0.0000394 AC XY: 28AN XY: 710214 show subpopulations
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152250Hom.: 0 Cov.: 33 AF XY: 0.0000538 AC XY: 4AN XY: 74386 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.503G>C (p.G168A) alteration is located in exon 5 (coding exon 2) of the ZSCAN25 gene. This alteration results from a G to C substitution at nucleotide position 503, causing the glycine (G) at amino acid position 168 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at